Loading company…
Xiaochuang Medical develops pulsed electric field ablation devices for digestive and metabolic diseases.
Founded in 2024 and based in Suzhou, China, Xiaochuang Medical develops devices using duodenal pulsed electric field ablation and related technologies. Its products include ablation equipment and disposable digestive tract catheters intended to treat type 2 diabetes. In May 2026, it raised Angel+ funding led by Oriza Holdings, with Suzhou High-tech Zone Science and Technology Angel Fund and Shanghai Hongye participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in